Wird geladen...

Neuroimmunomodulatory effects of transcranial laser therapy combined with intravenous tPA administration for acute cerebral ischemic injury

At present, the only FDA approved treatment for ischemic strokes is intravenous administration of tissue plasminogen activator within 4.5 hours of stroke onset. Owing to this brief window only a small percentage of patients receive tissue plasminogen activator. Transcranial laser therapy has been sh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neural Regen Res
1. Verfasser: Peplow, Philip V.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Medknow Publications & Media Pvt Ltd 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4590216/
https://ncbi.nlm.nih.gov/pubmed/26487831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.162687
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!